| Product Code: ETC8555715 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 New Zealand Cannabis Pharmaceutical Market Overview |
3.1 New Zealand Country Macro Economic Indicators |
3.2 New Zealand Cannabis Pharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 New Zealand Cannabis Pharmaceutical Market - Industry Life Cycle |
3.4 New Zealand Cannabis Pharmaceutical Market - Porter's Five Forces |
3.5 New Zealand Cannabis Pharmaceutical Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 New Zealand Cannabis Pharmaceutical Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.7 New Zealand Cannabis Pharmaceutical Market Revenues & Volume Share, By Compound Type, 2021 & 2031F |
3.8 New Zealand Cannabis Pharmaceutical Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 New Zealand Cannabis Pharmaceutical Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 New Zealand Cannabis Pharmaceutical Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 New Zealand Cannabis Pharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing acceptance of medical cannabis for various health conditions in New Zealand |
4.2.2 Growing awareness about the potential therapeutic benefits of cannabis pharmaceuticals |
4.2.3 Favorable government regulations supporting the use and research of cannabis-based medicines |
4.3 Market Restraints |
4.3.1 Limited availability of clinical evidence supporting the efficacy and safety of cannabis pharmaceuticals |
4.3.2 High costs associated with cannabis pharmaceutical research, development, and production |
4.3.3 Regulatory challenges and uncertainties surrounding the legal framework for cannabis-based medicines in New Zealand |
5 New Zealand Cannabis Pharmaceutical Market Trends |
6 New Zealand Cannabis Pharmaceutical Market, By Types |
6.1 New Zealand Cannabis Pharmaceutical Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 New Zealand Cannabis Pharmaceutical Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 New Zealand Cannabis Pharmaceutical Market Revenues & Volume, By Capsules, 2021- 2031F |
6.1.4 New Zealand Cannabis Pharmaceutical Market Revenues & Volume, By Concentrates, 2021- 2031F |
6.1.5 New Zealand Cannabis Pharmaceutical Market Revenues & Volume, By Edibles, 2021- 2031F |
6.2 New Zealand Cannabis Pharmaceutical Market, By Drugs |
6.2.1 Overview and Analysis |
6.2.2 New Zealand Cannabis Pharmaceutical Market Revenues & Volume, By Epidiolex, 2021- 2031F |
6.2.3 New Zealand Cannabis Pharmaceutical Market Revenues & Volume, By Marinol, 2021- 2031F |
6.2.4 New Zealand Cannabis Pharmaceutical Market Revenues & Volume, By Cesamet, 2021- 2031F |
6.2.5 New Zealand Cannabis Pharmaceutical Market Revenues & Volume, By Sativex, 2021- 2031F |
6.3 New Zealand Cannabis Pharmaceutical Market, By Compound Type |
6.3.1 Overview and Analysis |
6.3.2 New Zealand Cannabis Pharmaceutical Market Revenues & Volume, By Tetrahydrocannabinol (THC), 2021- 2031F |
6.3.3 New Zealand Cannabis Pharmaceutical Market Revenues & Volume, By Cannabidiol (CBD), 2021- 2031F |
6.3.4 New Zealand Cannabis Pharmaceutical Market Revenues & Volume, By Balanced THC & CBD, 2021- 2031F |
6.4 New Zealand Cannabis Pharmaceutical Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 New Zealand Cannabis Pharmaceutical Market Revenues & Volume, By Inflammation, 2021- 2031F |
6.4.3 New Zealand Cannabis Pharmaceutical Market Revenues & Volume, By Chronic Pain, 2021- 2031F |
6.4.4 New Zealand Cannabis Pharmaceutical Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.4.5 New Zealand Cannabis Pharmaceutical Market Revenues & Volume, By Sleep Disorders, 2021- 2031F |
6.4.6 New Zealand Cannabis Pharmaceutical Market Revenues & Volume, By Anorexia, 2021- 2031F |
6.4.7 New Zealand Cannabis Pharmaceutical Market Revenues & Volume, By Schizophrenia, 2021- 2031F |
6.5 New Zealand Cannabis Pharmaceutical Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 New Zealand Cannabis Pharmaceutical Market Revenues & Volume, By Clinic, 2021- 2031F |
6.5.3 New Zealand Cannabis Pharmaceutical Market Revenues & Volume, By Hospital, 2021- 2031F |
6.6 New Zealand Cannabis Pharmaceutical Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 New Zealand Cannabis Pharmaceutical Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 New Zealand Cannabis Pharmaceutical Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 New Zealand Cannabis Pharmaceutical Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 New Zealand Cannabis Pharmaceutical Market Import-Export Trade Statistics |
7.1 New Zealand Cannabis Pharmaceutical Market Export to Major Countries |
7.2 New Zealand Cannabis Pharmaceutical Market Imports from Major Countries |
8 New Zealand Cannabis Pharmaceutical Market Key Performance Indicators |
8.1 Number of clinical trials conducted on cannabis pharmaceuticals in New Zealand |
8.2 Percentage of healthcare professionals prescribing cannabis-based medicines |
8.3 Research and development investment in cannabis pharmaceuticals in New Zealand |
9 New Zealand Cannabis Pharmaceutical Market - Opportunity Assessment |
9.1 New Zealand Cannabis Pharmaceutical Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 New Zealand Cannabis Pharmaceutical Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.3 New Zealand Cannabis Pharmaceutical Market Opportunity Assessment, By Compound Type, 2021 & 2031F |
9.4 New Zealand Cannabis Pharmaceutical Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 New Zealand Cannabis Pharmaceutical Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 New Zealand Cannabis Pharmaceutical Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 New Zealand Cannabis Pharmaceutical Market - Competitive Landscape |
10.1 New Zealand Cannabis Pharmaceutical Market Revenue Share, By Companies, 2024 |
10.2 New Zealand Cannabis Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here